1058 related articles for article (PubMed ID: 25330803)
1. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.
Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH
Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803
[TBL] [Abstract][Full Text] [Related]
2. CCL3 promotes angiogenesis by dysregulation of miR-374b/ VEGF-A axis in human osteosarcoma cells.
Liao YY; Tsai HC; Chou PY; Wang SW; Chen HT; Lin YM; Chiang IP; Chang TM; Hsu SK; Chou MC; Tang CH; Fong YC
Oncotarget; 2016 Jan; 7(4):4310-25. PubMed ID: 26713602
[TBL] [Abstract][Full Text] [Related]
3. CCL5 promotes vascular endothelial growth factor expression and induces angiogenesis by down-regulating miR-199a in human chondrosarcoma cells.
Liu GT; Huang YL; Tzeng HE; Tsai CH; Wang SW; Tang CH
Cancer Lett; 2015 Feb; 357(2):476-87. PubMed ID: 25444917
[TBL] [Abstract][Full Text] [Related]
4. CCL5 promotes VEGF-dependent angiogenesis by down-regulating miR-200b through PI3K/Akt signaling pathway in human chondrosarcoma cells.
Liu GT; Chen HT; Tsou HK; Tan TW; Fong YC; Chen PC; Yang WH; Wang SW; Chen JC; Tang CH
Oncotarget; 2014 Nov; 5(21):10718-31. PubMed ID: 25301739
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 induces vascular endothelial growth factor expression and promotes angiogenesis through apoptosis signal-regulating kinase 1 in human osteosarcoma.
Tzeng HE; Tsai CH; Chang ZL; Su CM; Wang SW; Hwang WL; Tang CH
Biochem Pharmacol; 2013 Feb; 85(4):531-40. PubMed ID: 23219526
[TBL] [Abstract][Full Text] [Related]
6. Endothelin-1 promotes vascular endothelial growth factor-dependent angiogenesis in human chondrosarcoma cells.
Wu MH; Huang CY; Lin JA; Wang SW; Peng CY; Cheng HC; Tang CH
Oncogene; 2014 Mar; 33(13):1725-35. PubMed ID: 23584483
[TBL] [Abstract][Full Text] [Related]
7. [Effect of silencing HIF-1alpha by RNA interference on expression of vascular endothelial growth factor in osteosarcoma cell line SaOS-2 under hypoxia].
Wu Q; Yang SH; Wang RY; Ye SN; Xia T; Ma DZ
Ai Zheng; 2005 May; 24(5):531-5. PubMed ID: 15890092
[TBL] [Abstract][Full Text] [Related]
8. Basic fibroblast growth factor induces VEGF expression in chondrosarcoma cells and subsequently promotes endothelial progenitor cell-primed angiogenesis.
Tzeng HE; Chen PC; Lin KW; Lin CY; Tsai CH; Han SM; Teng CL; Hwang WL; Wang SW; Tang CH
Clin Sci (Lond); 2015 Jul; 129(2):147-58. PubMed ID: 25735814
[TBL] [Abstract][Full Text] [Related]
9. The CCL5/CCR5 axis promotes interleukin-6 production in human synovial fibroblasts.
Tang CH; Hsu CJ; Fong YC
Arthritis Rheum; 2010 Dec; 62(12):3615-24. PubMed ID: 20862675
[TBL] [Abstract][Full Text] [Related]
10. Vector-based RNAi approach to isoform-specific downregulation of vascular endothelial growth factor (VEGF)165 expression in human leukemia cells.
Shen HL; Xu W; Wu ZY; Zhou LL; Qin RJ; Tang HR
Leuk Res; 2007 Apr; 31(4):515-21. PubMed ID: 17034851
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin promotes VEGF-A-dependent angiogenesis in human chondrosarcoma through PI3K, Akt, mTOR, and HIF-α pathway.
Lee HP; Lin CY; Shih JS; Fong YC; Wang SW; Li TM; Tang CH
Oncotarget; 2015 Nov; 6(34):36746-61. PubMed ID: 26468982
[TBL] [Abstract][Full Text] [Related]
12. Cancer cell CCL5 mediates bone marrow independent angiogenesis in breast cancer.
Sax MJ; Gasch C; Athota VR; Freeman R; Rasighaemi P; Westcott DE; Day CJ; Nikolic I; Elsworth B; Wei M; Rogers K; Swarbrick A; Mittal V; Pouliot N; Mellick AS
Oncotarget; 2016 Dec; 7(51):85437-85449. PubMed ID: 27863423
[TBL] [Abstract][Full Text] [Related]
13. WISP-1 positively regulates angiogenesis by controlling VEGF-A expression in human osteosarcoma.
Tsai HC; Tzeng HE; Huang CY; Huang YL; Tsai CH; Wang SW; Wang PC; Chang AC; Fong YC; Tang CH
Cell Death Dis; 2017 Apr; 8(4):e2750. PubMed ID: 28406476
[TBL] [Abstract][Full Text] [Related]
14. VEGF Silencing Inhibits Human Osteosarcoma Angiogenesis and Promotes Cell Apoptosis via PI3K/AKT Signaling Pathway.
Zhao J; Zhang ZR; Zhao N; Ma BA; Fan QY
Cell Biochem Biophys; 2015 Nov; 73(2):519-525. PubMed ID: 27352347
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic effects of a novel synthetic curcumin analogue in pancreatic cancer.
Nagaraju GP; Zhu S; Ko JE; Ashritha N; Kandimalla R; Snyder JP; Shoji M; El-Rayes BF
Cancer Lett; 2015 Feb; 357(2):557-65. PubMed ID: 25497868
[TBL] [Abstract][Full Text] [Related]
16. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of factor inhibiting HIF-1 enhances vessel maturation and tumor growth via platelet-derived growth factor-C.
Kuzmanov A; Wielockx B; Rezaei M; Kettelhake A; Breier G
Int J Cancer; 2012 Sep; 131(5):E603-13. PubMed ID: 22095574
[TBL] [Abstract][Full Text] [Related]
18. A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model.
Guan H; Zhou Z; Wang H; Jia SF; Liu W; Kleinerman ES
Clin Cancer Res; 2005 Apr; 11(7):2662-9. PubMed ID: 15814647
[TBL] [Abstract][Full Text] [Related]
19. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways.
Lin J; Chen Y; Wei L; Hong Z; Sferra TJ; Peng J
Int J Oncol; 2013 Nov; 43(5):1666-74. PubMed ID: 24042330
[TBL] [Abstract][Full Text] [Related]
20. CCL5/CCR5 axis promotes the motility of human oral cancer cells.
Chuang JY; Yang WH; Chen HT; Huang CY; Tan TW; Lin YT; Hsu CJ; Fong YC; Tang CH
J Cell Physiol; 2009 Aug; 220(2):418-26. PubMed ID: 19334035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
